JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 13, Issue 8, Pages 750-758
Publisher
Wiley
Online
2011-03-30
DOI
10.1111/j.1463-1326.2011.01402.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- When NRF2 Talks, Who's Listening?
- (2010) Nobunao Wakabayashi et al. ANTIOXIDANTS & REDOX SIGNALING
- NF-κB inhibitory action of resveratrol: A probable mechanism of neuroprotection in experimental diabetic neuropathy
- (2010) Ashutosh Kumar et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of nitric oxide produced by iNOS through NF-κB pathway in migration of cerebellar granule neurons induced by Lipopolysaccharide
- (2010) Daniela Arias-Salvatierra et al. CELLULAR SIGNALLING
- Concurrent targeting of nitrosative stress–PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy
- (2009) Geeta Negi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: Focus on functional, sensorimotor and biochemical changes
- (2009) Shyam S. Sharma et al. FREE RADICAL RESEARCH
- Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy
- (2009) Geeta Negi et al. NEUROPHARMACOLOGY
- NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK
- (2008) Guang-Hui Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Editorial [Hot Topic: Diabetic Neuropathy (Guest Editor: Eva L. Feldman)]
- (2008) Eva Feldman CURRENT DRUG TARGETS
- Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway
- (2008) Norman Cameron et al. CURRENT DRUG TARGETS
- Sulfasalazine Blocks the Development of Tactile Allodynia in Diabetic Rats
- (2008) L. N. Berti-Mattera et al. DIABETES
- Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy
- (2008) Manish Arora et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy
- (2008) Yang Zhao et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy
- (2008) Shyam S. Sharma et al. LIFE SCIENCES
- Diabetic neuropathy: Mechanisms to management
- (2008) James L. Edwards et al. PHARMACOLOGY & THERAPEUTICS
- Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
- (2007) Leonel E. Rojo et al. ARCHIVES OF MEDICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started